{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T16:06:40Z","timestamp":1786982800068,"version":"build-2736575974"},"reference-count":158,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"},{"start":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T00:00:00Z","timestamp":1673049600000},"content-version":"vor","delay-in-days":6,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc\/4.0"}],"funder":[{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Med"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1007\/s40290-022-00453-9","type":"journal-article","created":{"date-parts":[[2023,1,7]],"date-time":"2023-01-07T12:06:21Z","timestamp":1673093181000},"page":"37-52","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Drug-Induced Gambling Disorder: Epidemiology, Neurobiology, and Management"],"prefix":"10.1007","volume":"37","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5215-0276","authenticated-orcid":false,"given":"Mirjam","family":"Wolfschlag","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5800-8975","authenticated-orcid":false,"given":"Anders","family":"H\u00e5kansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,1,7]]},"reference":[{"key":"453_CR1","doi-asserted-by":"crossref","unstructured":"American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders 5th edn. 2013","DOI":"10.1176\/appi.books.9780890425596"},{"key":"453_CR2","unstructured":"World Health Organization. 6C50 Gambling Disorder. In: ICD-11 for Mortality and Morbidity Statistics (Version: 09\/2020). World Health Organization, 2020 https:\/\/icd.who.int\/browse11\/l-m\/en#\/http%3a%2f%2fid.who.int%2ficd%2fentity%2f1041487064."},{"issue":"4","key":"453_CR3","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1556\/2006.5.2016.073","volume":"5","author":"F Calado","year":"2016","unstructured":"Calado F, Griffiths MD. Problem gambling worldwide: an update and systematic review of empirical research (2000\u20132015). J Behav Addict. 2016;5(4):592\u2013613. https:\/\/doi.org\/10.1556\/2006.5.2016.073.","journal-title":"J Behav Addict"},{"issue":"1","key":"453_CR4","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1038\/s41572-019-0099-7","volume":"5","author":"MN Potenza","year":"2019","unstructured":"Potenza MN, Balodis IM, Derevensky J, Grant JE, Petry NM, Verdejo-Garcia A, et al. Gambling disorder. Nat Rev Dis Primers. 2019;5(1):51. https:\/\/doi.org\/10.1038\/s41572-019-0099-7.","journal-title":"Nat Rev Dis Primers"},{"issue":"1","key":"453_CR5","doi-asserted-by":"publisher","first-page":"45","DOI":"10.1186\/s12954-018-0251-9","volume":"15","author":"A Oksanen","year":"2018","unstructured":"Oksanen A, Savolainen I, Sirola A, Kaakinen M. Problem gambling and psychological distress: a cross-national perspective on the mediating effect of consumer debt and debt problems among emerging adults. Harm Reduct J. 2018;15(1):45. https:\/\/doi.org\/10.1186\/s12954-018-0251-9.","journal-title":"Harm Reduct J"},{"key":"453_CR6","doi-asserted-by":"publisher","first-page":"7","DOI":"10.3389\/fpsyt.2020.00007","volume":"11","author":"A H\u00e5kansson","year":"2020","unstructured":"H\u00e5kansson A, Widinghoff C. Over-indebtedness and problem gambling in a general population sample of online gamblers. Front Psych. 2020;11:7. https:\/\/doi.org\/10.3389\/fpsyt.2020.00007.","journal-title":"Front Psych"},{"issue":"3","key":"453_CR7","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1038\/s41562-020-01045-w","volume":"5","author":"N Muggleton","year":"2021","unstructured":"Muggleton N, Parpart P, Newall P, Leake D, Gathergood J, Stewart N. The association between gambling and financial, social and health outcomes in big financial data. Nat Hum Behav. 2021;5(3):319\u201326. https:\/\/doi.org\/10.1038\/s41562-020-01045-w.","journal-title":"Nat Hum Behav"},{"issue":"6","key":"453_CR8","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1177\/0004867415575774","volume":"49","author":"NA Dowling","year":"2015","unstructured":"Dowling NA, Cowlishaw S, Jackson AC, Merkouris SS, Francis KL, Christensen DR. Prevalence of psychiatric co-morbidity in treatment-seeking problem gamblers: a systematic review and meta-analysis. Aust N Z J Psychiatry. 2015;49(6):519\u201339. https:\/\/doi.org\/10.1177\/0004867415575774.","journal-title":"Aust N Z J Psychiatry"},{"issue":"3","key":"453_CR9","doi-asserted-by":"publisher","first-page":"490","DOI":"10.1111\/j.1360-0443.2010.03300.x","volume":"106","author":"FK Lorains","year":"2011","unstructured":"Lorains FK, Cowlishaw S, Thomas SA. Prevalence of comorbid disorders in problem and pathological gambling: systematic review and meta-analysis of population surveys. Addiction (Abingdon, England). 2011;106(3):490\u20138. https:\/\/doi.org\/10.1111\/j.1360-0443.2010.03300.x.","journal-title":"Addiction (Abingdon, England)."},{"key":"453_CR10","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1016\/j.comppsych.2012.07.001","volume":"54","author":"DW Black","year":"2013","unstructured":"Black DW, Shaw M, McCormick B, Allen J. Pathological gambling: relationship to obesity, self-reported chronic medical conditions, poor lifestyle choices, and impaired quality of life. Compr Psychiatry. 2013;54:97\u2013104. https:\/\/doi.org\/10.1016\/j.comppsych.2012.07.001.","journal-title":"Compr Psychiatry"},{"issue":"2","key":"453_CR11","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1007\/s40429-019-00240-8","volume":"6","author":"A Kayser","year":"2019","unstructured":"Kayser A. Dopamine and gambling disorder: prospects for personalized treatment. Curr Addict Rep. 2019;6(2):65\u201374. https:\/\/doi.org\/10.1007\/s40429-019-00240-8.","journal-title":"Curr Addict Rep"},{"key":"453_CR12","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2019.109853","volume":"99","author":"M Zack","year":"2020","unstructured":"Zack M, St George R, Clark L. Dopaminergic signaling of uncertainty and the aetiology of gambling addiction. Prog Neuropsychopharmacol Biol Psychiatry. 2020;99: 109853. https:\/\/doi.org\/10.1016\/j.pnpbp.2019.109853.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"3","key":"453_CR13","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.psychres.2014.03.033","volume":"217","author":"SM Gainsbury","year":"2014","unstructured":"Gainsbury SM, Suhonen N, Saastamoinen J. Chasing losses in online poker and casino games: characteristics and game play of Internet gamblers at risk of disordered gambling. Psychiatry Res. 2014;217(3):220\u20135. https:\/\/doi.org\/10.1016\/j.psychres.2014.03.033.","journal-title":"Psychiatry Res"},{"issue":"2","key":"453_CR14","doi-asserted-by":"publisher","first-page":"749","DOI":"10.1007\/s10899-015-9558-6","volume":"32","author":"M Ch\u00f3liz","year":"2016","unstructured":"Ch\u00f3liz M. The challenge of online gambling: the effect of legalization on the increase in online gambling addiction. J Gambl Stud. 2016;32(2):749\u201356. https:\/\/doi.org\/10.1007\/s10899-015-9558-6.","journal-title":"J Gambl Stud"},{"issue":"7598","key":"453_CR15","doi-asserted-by":"publisher","first-page":"810","DOI":"10.1136\/bmj.39176.363958.80","volume":"334","author":"SH Wong","year":"2007","unstructured":"Wong SH, Steiger MJ. Pathological gambling in Parkinson\u2019s disease. BMJ. 2007;334(7598):810\u20131. https:\/\/doi.org\/10.1136\/bmj.39176.363958.80.","journal-title":"BMJ"},{"issue":"5","key":"453_CR16","doi-asserted-by":"publisher","first-page":"589","DOI":"10.1001\/archneurol.2010.65","volume":"67","author":"D Weintraub","year":"2010","unstructured":"Weintraub D, Koester J, Potenza MN, Siderowf AD, Stacy M, Voon V, et al. Impulse control disorders in Parkinson disease: a cross-sectional study of 3090 patients. Arch Neurol. 2010;67(5):589\u201395. https:\/\/doi.org\/10.1001\/archneurol.2010.65.","journal-title":"Arch Neurol"},{"issue":"4","key":"453_CR17","doi-asserted-by":"publisher","first-page":"502","DOI":"10.1016\/j.neuron.2009.01.031","volume":"61","author":"A Dagher","year":"2009","unstructured":"Dagher A, Robbins TW. Personality, addiction, dopamine: insights from Parkinson\u2019s disease. Neuron. 2009;61(4):502\u201310. https:\/\/doi.org\/10.1016\/j.neuron.2009.01.031.","journal-title":"Neuron"},{"key":"453_CR18","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1016\/j.addbeh.2017.05.032","volume":"74","author":"S Ronzitti","year":"2017","unstructured":"Ronzitti S, Soldini E, Smith N, Potenza MN, Clerici M, Bowden-Jones H. Current suicidal ideation in treatment-seeking individuals in the United Kingdom with gambling problems. Addict Behav. 2017;74:33\u201340. https:\/\/doi.org\/10.1016\/j.addbeh.2017.05.032.","journal-title":"Addict Behav"},{"issue":"4","key":"453_CR19","doi-asserted-by":"publisher","first-page":"1091","DOI":"10.1556\/2006.7.2018.112","volume":"7","author":"A Karlsson","year":"2018","unstructured":"Karlsson A, H\u00e5kansson A. Gambling disorder, increased mortality, suicidality, and associated comorbidity: a longitudinal nationwide register study. J Behav Addict. 2018;7(4):1091\u20139. https:\/\/doi.org\/10.1556\/2006.7.2018.112.","journal-title":"J Behav Addict"},{"key":"453_CR20","doi-asserted-by":"publisher","DOI":"10.1177\/00207640211036166","author":"Y Rojas","year":"2021","unstructured":"Rojas Y. Financial indebtedness and suicide: a 1-year follow-up study of a population registered at the Swedish Enforcement Authority. Int J Soc Psychiatry. 2021. https:\/\/doi.org\/10.1177\/00207640211036166.","journal-title":"Int J Soc Psychiatry"},{"issue":"1","key":"453_CR21","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0227644","volume":"15","author":"M Ford","year":"2020","unstructured":"Ford M, H\u00e5kansson A. Problem gambling, associations with comorbid health conditions, substance use, and behavioural addictions: Opportunities for pathways to treatment. PLoS ONE. 2020;15(1): e0227644. https:\/\/doi.org\/10.1371\/journal.pone.0227644.","journal-title":"PLoS ONE"},{"key":"453_CR22","doi-asserted-by":"publisher","first-page":"122","DOI":"10.1016\/j.comppsych.2015.01.003","volume":"58","author":"M Haydock","year":"2015","unstructured":"Haydock M, Cowlishaw S, Harvey C, Castle D. Prevalence and correlates of problem gambling in people with psychotic disorders. Compr Psychiatry. 2015;58:122\u20139. https:\/\/doi.org\/10.1016\/j.comppsych.2015.01.003.","journal-title":"Compr Psychiatry"},{"issue":"1","key":"453_CR23","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1097\/jcp.0000000000000444","volume":"36","author":"M Grall-Bronnec","year":"2016","unstructured":"Grall-Bronnec M, Sauvaget A, Perrouin F, Leboucher J, Etcheverrigaray F, Challet-Bouju G, et al. Pathological gambling associated with aripiprazole or dopamine replacement therapy: do patients share the same features? A review. J Clin Psychopharmacol. 2016;36(1):63\u201370. https:\/\/doi.org\/10.1097\/jcp.0000000000000444.","journal-title":"J Clin Psychopharmacol"},{"issue":"4","key":"453_CR24","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1097\/jcp.0000000000001068","volume":"39","author":"A Lachance","year":"2019","unstructured":"Lachance A, Corbeil O, Corbeil S, Chalifour G, Breault AS, Roy MA, et al. Case reports of aripiprazole and problematic gambling in schizophrenia: a critical review of the evidence. J Clin Psychopharmacol. 2019;39(4):393\u20137. https:\/\/doi.org\/10.1097\/jcp.0000000000001068.","journal-title":"J Clin Psychopharmacol"},{"issue":"3","key":"453_CR25","doi-asserted-by":"publisher","first-page":"757","DOI":"10.1007\/s10899-019-09851-2","volume":"35","author":"K Sundqvist","year":"2019","unstructured":"Sundqvist K, Rosendahl I. Problem gambling and psychiatric comorbidity-risk and temporal sequencing among women and men: results from the Swelogs case-control study. J Gambl Stud. 2019;35(3):757\u201371. https:\/\/doi.org\/10.1007\/s10899-019-09851-2.","journal-title":"J Gambl Stud"},{"key":"453_CR26","doi-asserted-by":"publisher","first-page":"272","DOI":"10.1016\/j.addbeh.2018.06.001","volume":"87","author":"SN Rodda","year":"2018","unstructured":"Rodda SN, Dowling NA, Lubman DI. Gamblers seeking online help are active help-seekers: time to support autonomy and competence. Addict Behav. 2018;87:272\u20135. https:\/\/doi.org\/10.1016\/j.addbeh.2018.06.001.","journal-title":"Addict Behav"},{"issue":"2","key":"453_CR27","doi-asserted-by":"publisher","first-page":"503","DOI":"10.1007\/s10899-013-9373-x","volume":"30","author":"S Gainsbury","year":"2014","unstructured":"Gainsbury S, Hing N, Suhonen N. Professional help-seeking for gambling problems: awareness, barriers and motivators for treatment. J Gambl Stud. 2014;30(2):503\u201319. https:\/\/doi.org\/10.1007\/s10899-013-9373-x.","journal-title":"J Gambl Stud"},{"issue":"1","key":"453_CR28","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1111\/add.12717","volume":"110","author":"WS Slutske","year":"2015","unstructured":"Slutske WS, Piasecki TM, Deutsch AR, Statham DJ, Martin NG. Telescoping and gender differences in the time course of disordered gambling: evidence from a general population sample. Addiction (Abingdon, England). 2015;110(1):144\u201351. https:\/\/doi.org\/10.1111\/add.12717.","journal-title":"Addiction (Abingdon, England)."},{"issue":"1","key":"453_CR29","doi-asserted-by":"publisher","first-page":"22","DOI":"10.1186\/s12954-018-0227-9","volume":"15","author":"S McCarthy","year":"2018","unstructured":"McCarthy S, Thomas SL, Randle M, Bestman A, Pitt H, Cowlishaw S, et al. Women\u2019s gambling behaviour, product preferences, and perceptions of product harm: differences by age and gambling risk status. Harm Reduct J. 2018;15(1):22. https:\/\/doi.org\/10.1186\/s12954-018-0227-9.","journal-title":"Harm Reduct J"},{"issue":"4","key":"453_CR30","doi-asserted-by":"publisher","first-page":"433","DOI":"10.4088\/jcp.v64n0413","volume":"64","author":"H Tavares","year":"2003","unstructured":"Tavares H, Martins SS, Lobo DS, Silveira CM, Gentil V, Hodgins DC. Factors at play in faster progression for female pathological gamblers: an exploratory analysis. J Clin Psychiatry. 2003;64(4):433\u20138. https:\/\/doi.org\/10.4088\/jcp.v64n0413.","journal-title":"J Clin Psychiatry"},{"key":"453_CR31","doi-asserted-by":"publisher","first-page":"1510","DOI":"10.3389\/fpsyg.2017.01510","volume":"8","author":"Y Zakiniaeiz","year":"2017","unstructured":"Zakiniaeiz Y, Cosgrove KP, Mazure CM, Potenza MN. Does telescoping exist in male and female gamblers? does it matter? Front Psychol. 2017;8:1510. https:\/\/doi.org\/10.3389\/fpsyg.2017.01510.","journal-title":"Front Psychol"},{"issue":"4","key":"453_CR32","doi-asserted-by":"publisher","first-page":"300","DOI":"10.1017\/s1092852916000183","volume":"21","author":"JE Grant","year":"2016","unstructured":"Grant JE, Chamberlain SR. Expanding the definition of addiction: DSM-5 vs. ICD-11. CNS Spectr. 2016;21(4):300\u20133. https:\/\/doi.org\/10.1017\/s1092852916000183.","journal-title":"CNS Spectr"},{"issue":"2","key":"453_CR33","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1111\/ajad.12112","volume":"24","author":"JE Grant","year":"2015","unstructured":"Grant JE, Chamberlain SR. Gambling disorder and its relationship with substance use disorders: implications for nosological revisions and treatment. Am J Addict. 2015;24(2):126\u201331. https:\/\/doi.org\/10.1111\/ajad.12112.","journal-title":"Am J Addict"},{"issue":"10","key":"453_CR34","doi-asserted-by":"publisher","first-page":"1418","DOI":"10.2174\/1570159x15666170718144058","volume":"16","author":"C Victorri-Vigneau","year":"2018","unstructured":"Victorri-Vigneau C, Spiers A, Caillet P, Bruneau M, Ignace C, Challet-Bouju G, et al. Opioid antagonists for pharmacological treatment of gambling disorder: are they relevant? Curr Neuropharmacol. 2018;16(10):1418\u201332. https:\/\/doi.org\/10.2174\/1570159x15666170718144058.","journal-title":"Curr Neuropharmacol"},{"key":"453_CR35","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2019.109847","volume":"99","author":"IM Balodis","year":"2020","unstructured":"Balodis IM, Potenza MN. Common neurobiological and psychological underpinnings of gambling and substance-use disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2020;99: 109847. https:\/\/doi.org\/10.1016\/j.pnpbp.2019.109847.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"1","key":"453_CR36","doi-asserted-by":"publisher","first-page":"83","DOI":"10.1186\/s12929-021-00779-7","volume":"28","author":"RA Wise","year":"2021","unstructured":"Wise RA, Jordan CJ. Dopamine, behavior, and addiction. J Biomed Sci. 2021;28(1):83. https:\/\/doi.org\/10.1186\/s12929-021-00779-7.","journal-title":"J Biomed Sci"},{"key":"453_CR37","doi-asserted-by":"publisher","first-page":"224","DOI":"10.1016\/j.neubiorev.2021.02.007","volume":"124","author":"E Galaj","year":"2021","unstructured":"Galaj E, Ranaldi R. Neurobiology of reward-related learning. Neurosci Biobehav Rev. 2021;124:224\u201334. https:\/\/doi.org\/10.1016\/j.neubiorev.2021.02.007.","journal-title":"Neurosci Biobehav Rev"},{"key":"453_CR38","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8081086","author":"A Heinz","year":"2019","unstructured":"Heinz A, Beck A, Halil MG, Pilhatsch M, Smolka MN, Liu S. Addiction as learned behavior patterns. J Clin Med. 2019. https:\/\/doi.org\/10.3390\/jcm8081086.","journal-title":"J Clin Med"},{"issue":"1","key":"453_CR39","doi-asserted-by":"publisher","first-page":"62","DOI":"10.1017\/s1092852913000722","volume":"19","author":"GS Berlin","year":"2014","unstructured":"Berlin GS, Hollander E. Compulsivity, impulsivity, and the DSM-5 process. CNS Spectr. 2014;19(1):62\u20138. https:\/\/doi.org\/10.1017\/s1092852913000722.","journal-title":"CNS Spectr"},{"issue":"4","key":"453_CR40","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1007\/s10899-016-9593-y","volume":"32","author":"M Ciccarelli","year":"2016","unstructured":"Ciccarelli M, Malinconico R, Griffiths MD, Nigro G, Cosenza M. Reward preferences of pathological gamblers under conditions of uncertainty: an experimental study. J Gambl Stud. 2016;32(4):1175\u201389. https:\/\/doi.org\/10.1007\/s10899-016-9593-y.","journal-title":"J Gambl Stud"},{"key":"453_CR41","doi-asserted-by":"publisher","first-page":"496","DOI":"10.1016\/j.jad.2020.03.144","volume":"272","author":"M Ciccarelli","year":"2020","unstructured":"Ciccarelli M, Griffiths MD, Cosenza M, Nigro G, D\u2019Olimpio F. Disordered gambling and attentional bias: the mediating role of risk-taking. J Affect Disord. 2020;272:496\u2013500. https:\/\/doi.org\/10.1016\/j.jad.2020.03.144.","journal-title":"J Affect Disord"},{"issue":"2","key":"453_CR42","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1007\/s10899-016-9623-9","volume":"33","author":"M Cosenza","year":"2017","unstructured":"Cosenza M, Griffiths MD, Nigro G, Ciccarelli M. Risk-taking, delay discounting, and time perspective in adolescent gamblers: an experimental study. J Gambl Stud. 2017;33(2):383\u201395. https:\/\/doi.org\/10.1007\/s10899-016-9623-9.","journal-title":"J Gambl Stud"},{"issue":"1","key":"453_CR43","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1007\/s10899-016-9608-8","volume":"33","author":"S Mishra","year":"2017","unstructured":"Mishra S, Lalumi\u00e8re ML, Williams RJ. Gambling, risk-taking, and antisocial behavior: a replication study supporting the generality of deviance. J Gambl Stud. 2017;33(1):15\u201336. https:\/\/doi.org\/10.1007\/s10899-016-9608-8.","journal-title":"J Gambl Stud"},{"issue":"3","key":"453_CR44","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.pharmthera.2012.02.004","volume":"134","author":"WK Bickel","year":"2012","unstructured":"Bickel WK, Jarmolowicz DP, Mueller ET, Koffarnus MN, Gatchalian KM. Excessive discounting of delayed reinforcers as a trans-disease process contributing to addiction and other disease-related vulnerabilities: emerging evidence. Pharmacol Ther. 2012;134(3):287\u201397. https:\/\/doi.org\/10.1016\/j.pharmthera.2012.02.004.","journal-title":"Pharmacol Ther"},{"key":"453_CR45","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2021.786358","volume":"15","author":"S Weinsztok","year":"2021","unstructured":"Weinsztok S, Brassard S, Balodis I, Martin LE, Amlung M. Delay discounting in established and proposed behavioral addictions: a systematic review and meta-analysis. Front Behav Neurosci. 2021;15: 786358. https:\/\/doi.org\/10.3389\/fnbeh.2021.786358.","journal-title":"Front Behav Neurosci"},{"issue":"3","key":"453_CR46","doi-asserted-by":"publisher","first-page":"359","DOI":"10.1007\/s10899-012-9315-z","volume":"29","author":"A H\u00f8nsi","year":"2013","unstructured":"H\u00f8nsi A, Mentzoni RA, Molde H, Pallesen S. Attentional bias in problem gambling: a systematic review. J Gambl Stud. 2013;29(3):359\u201375. https:\/\/doi.org\/10.1007\/s10899-012-9315-z.","journal-title":"J Gambl Stud"},{"key":"453_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2020.109861","volume":"99","author":"P Anselme","year":"2020","unstructured":"Anselme P, Robinson MJF. From sign-tracking to attentional bias: Implications for gambling and substance use disorders. Prog Neuropsychopharmacol Biol Psychiatry. 2020;99: 109861. https:\/\/doi.org\/10.1016\/j.pnpbp.2020.109861.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"2","key":"453_CR48","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1111\/add.14071","volume":"113","author":"M Boffo","year":"2018","unstructured":"Boffo M, Smits R, Salmon JP, Cowie ME, de Jong DTHA, Salemink E, et al. Luck, come here! Automatic approach tendencies toward gambling cues in moderate- to high-risk gamblers. Addiction (Abingdon, England). 2018;113(2):289\u201398. https:\/\/doi.org\/10.1111\/add.14071.","journal-title":"Addiction (Abingdon, England)."},{"key":"453_CR49","doi-asserted-by":"publisher","first-page":"100","DOI":"10.4309\/jgi.2016.34.6","volume":"34","author":"A Hudson","year":"2016","unstructured":"Hudson A, Olatunji BO, Gough K, Yi S, Stewart SH. Eye on the prize: high-risk gamblers show sustained selective attention to gambling cues. J Gambling Issues. 2016;34:100\u201319. https:\/\/doi.org\/10.4309\/jgi.2016.34.6.","journal-title":"J Gambling Issues"},{"issue":"4","key":"453_CR50","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1007\/s10899-017-9688-0","volume":"33","author":"KR Barton","year":"2017","unstructured":"Barton KR, Yazdani A, Ayer N, Kalvapalle S, Brown S, Stapleton J, et al. The effect of losses disguised as wins and near misses in electronic gaming machines: a systematic review. J Gambl Stud. 2017;33(4):1241\u201360. https:\/\/doi.org\/10.1007\/s10899-017-9688-0.","journal-title":"J Gambl Stud"},{"issue":"4","key":"453_CR51","doi-asserted-by":"publisher","first-page":"660","DOI":"10.1016\/j.conb.2013.03.004","volume":"23","author":"MN Potenza","year":"2013","unstructured":"Potenza MN. Neurobiology of gambling behaviors. Curr Opin Neurobiol. 2013;23(4):660\u20137. https:\/\/doi.org\/10.1016\/j.conb.2013.03.004.","journal-title":"Curr Opin Neurobiol"},{"issue":"1","key":"453_CR52","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1007\/s10571-018-0632-3","volume":"39","author":"MO Klein","year":"2019","unstructured":"Klein MO, Battagello DS, Cardoso AR, Hauser DN, Bittencourt JC, Correa RG. Dopamine: functions, signaling, and association with neurological diseases. Cell Mol Neurobiol. 2019;39(1):31\u201359. https:\/\/doi.org\/10.1007\/s10571-018-0632-3.","journal-title":"Cell Mol Neurobiol"},{"issue":"Pt 5","key":"453_CR53","doi-asserted-by":"publisher","first-page":"1376","DOI":"10.1093\/brain\/awp054","volume":"132","author":"TD Steeves","year":"2009","unstructured":"Steeves TD, Miyasaki J, Zurowski M, Lang AE, Pellecchia G, Van Eimeren T, et al. Increased striatal dopamine release in Parkinsonian patients with pathological gambling: a [11C] raclopride PET study. Brain J Neurol. 2009;132(Pt 5):1376\u201385. https:\/\/doi.org\/10.1093\/brain\/awp054.","journal-title":"Brain J Neurol."},{"issue":"1","key":"453_CR54","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1016\/j.pscychresns.2012.04.012","volume":"204","author":"J Linnet","year":"2012","unstructured":"Linnet J, Mouridsen K, Peterson E, M\u00f8ller A, Doudet DJ, Gjedde A. Striatal dopamine release codes uncertainty in pathological gambling. Psychiatry Res. 2012;204(1):55\u201360. https:\/\/doi.org\/10.1016\/j.pscychresns.2012.04.012.","journal-title":"Psychiatry Res"},{"issue":"5","key":"453_CR55","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1038\/s41380-018-0230-2","volume":"24","author":"L Clark","year":"2019","unstructured":"Clark L, Boileau I, Zack M. Neuroimaging of reward mechanisms in Gambling disorder: an integrative review. Mol Psychiatry. 2019;24(5):674\u201393. https:\/\/doi.org\/10.1038\/s41380-018-0230-2.","journal-title":"Mol Psychiatry"},{"issue":"6","key":"453_CR56","doi-asserted-by":"publisher","first-page":"1586","DOI":"10.1212\/con.0000000000001009","volume":"27","author":"DT Jones","year":"2021","unstructured":"Jones DT, Graff-Radford J. Executive dysfunction and the prefrontal cortex. Continuum (Minneap Minn). 2021;27(6):1586\u2013601. https:\/\/doi.org\/10.1212\/con.0000000000001009.","journal-title":"Continuum (Minneap Minn)."},{"issue":"9","key":"453_CR57","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11910-019-0980-5","volume":"19","author":"AA Roussakis","year":"2019","unstructured":"Roussakis AA, Lao-Kaim NP, Piccini P. Brain imaging and impulse control disorders in Parkinson\u2019s disease. Curr Neurol Neurosci Rep. 2019;19(9):67. https:\/\/doi.org\/10.1007\/s11910-019-0980-5.","journal-title":"Curr Neurol Neurosci Rep"},{"key":"453_CR58","doi-asserted-by":"publisher","first-page":"561","DOI":"10.1016\/j.nbd.2015.08.026","volume":"82","author":"MA Cenci","year":"2015","unstructured":"Cenci MA, Francardo V, O\u2019Sullivan SS, Lindgren HS. Rodent models of impulsive-compulsive behaviors in Parkinson\u2019s disease: how far have we reached? Neurobiol Dis. 2015;82:561\u201373. https:\/\/doi.org\/10.1016\/j.nbd.2015.08.026.","journal-title":"Neurobiol Dis"},{"key":"453_CR59","doi-asserted-by":"publisher","first-page":"93","DOI":"10.1007\/7854_2015_5014","volume":"28","author":"CA Winstanley","year":"2016","unstructured":"Winstanley CA, Clark L. Translational models of gambling-related decision-making. Curr Top Behav Neurosci. 2016;28:93\u2013120. https:\/\/doi.org\/10.1007\/7854_2015_5014.","journal-title":"Curr Top Behav Neurosci"},{"issue":"1","key":"453_CR60","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1002\/hbm.23860","volume":"39","author":"K Petersen","year":"2018","unstructured":"Petersen K, Van Wouwe N, Stark A, Lin YC, Kang H, Trujillo-Diaz P, et al. Ventral striatal network connectivity reflects reward learning and behavior in patients with Parkinson\u2019s disease. Hum Brain Mapp. 2018;39(1):509\u201321. https:\/\/doi.org\/10.1002\/hbm.23860.","journal-title":"Hum Brain Mapp"},{"issue":"12","key":"453_CR61","doi-asserted-by":"publisher","first-page":"3917","DOI":"10.1093\/brain\/awz327","volume":"142","author":"PE Mosley","year":"2019","unstructured":"Mosley PE, Paliwal S, Robinson K, Coyne T, Silburn P, Tittgemeyer M, et al. The structural connectivity of discrete networks underlies impulsivity and gambling in Parkinson\u2019s disease. Brain J Neurol. 2019;142(12):3917\u201335. https:\/\/doi.org\/10.1093\/brain\/awz327.","journal-title":"Brain J Neurol."},{"key":"453_CR62","doi-asserted-by":"publisher","first-page":"317","DOI":"10.3389\/fnbeh.2015.00317","volume":"9","author":"M Tahmasian","year":"2015","unstructured":"Tahmasian M, Rochhausen L, Maier F, Williamson KL, Drzezga A, Timmermann L, et al. Impulsivity is associated with increased metabolism in the fronto-insular network in Parkinson\u2019s disease. Front Behav Neurosci. 2015;9:317. https:\/\/doi.org\/10.3389\/fnbeh.2015.00317.","journal-title":"Front Behav Neurosci"},{"key":"453_CR63","doi-asserted-by":"publisher","DOI":"10.1016\/j.brainres.2021.147479","volume":"1764","author":"C Schmidt","year":"2021","unstructured":"Schmidt C, Gleesborg C, Schmidt H, Kvamme TL, Lund TE, Voon V, et al. A bias towards natural rewards away from gambling cues in gamblers undergoing active treatment. Brain Res. 2021;1764: 147479. https:\/\/doi.org\/10.1016\/j.brainres.2021.147479.","journal-title":"Brain Res"},{"key":"453_CR64","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1016\/j.bbr.2017.06.016","volume":"332","author":"D Dardou","year":"2017","unstructured":"Dardou D, Reyrolle L, Chassain C, Durif F. Chronic pramipexole treatment induces compulsive behavior in rats with 6-OHDA lesions of the substantia nigra and ventral tegmental area. Behav Brain Res. 2017;332:327\u201336. https:\/\/doi.org\/10.1016\/j.bbr.2017.06.016.","journal-title":"Behav Brain Res"},{"key":"453_CR65","doi-asserted-by":"publisher","first-page":"462","DOI":"10.3389\/fnhum.2018.00462","volume":"12","author":"P Filip","year":"2018","unstructured":"Filip P, Linhartov\u00e1 P, Hlavat\u00e1 P, \u0160umec R, Bal\u00e1\u017e M, Bare\u0161 M, et al. Disruption of multiple distinctive neural networks associated with impulse control disorder in Parkinson\u2019s disease. Front Hum Neurosci. 2018;12:462. https:\/\/doi.org\/10.3389\/fnhum.2018.00462.","journal-title":"Front Hum Neurosci"},{"issue":"3","key":"453_CR66","doi-asserted-by":"publisher","first-page":"733","DOI":"10.1093\/brain\/awz007","volume":"142","author":"J Hammes","year":"2019","unstructured":"Hammes J, Theis H, Giehl K, Hoenig MC, Greuel A, Tittgemeyer M, et al. Dopamine metabolism of the nucleus accumbens and fronto-striatal connectivity modulate impulse control. Brain J Neurol. 2019;142(3):733\u201343. https:\/\/doi.org\/10.1093\/brain\/awz007.","journal-title":"Brain J Neurol."},{"issue":"11","key":"453_CR67","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1002\/mds.23147","volume":"25","author":"H Rao","year":"2010","unstructured":"Rao H, Mamikonyan E, Detre JA, Siderowf AD, Stern MB, Potenza MN, et al. Decreased ventral striatal activity with impulse control disorders in Parkinson\u2019s disease. Mov Disord. 2010;25(11):1660\u20139. https:\/\/doi.org\/10.1002\/mds.23147.","journal-title":"Mov Disord."},{"issue":"19","key":"453_CR68","doi-asserted-by":"publisher","first-page":"1711","DOI":"10.1212\/WNL.0b013e3181fc27fa","volume":"75","author":"T van Eimeren","year":"2010","unstructured":"van Eimeren T, Pellecchia G, Cilia R, Ballanger B, Steeves TD, Houle S, et al. Drug-induced deactivation of inhibitory networks predicts pathological gambling in PD. Neurology. 2010;75(19):1711\u20136. https:\/\/doi.org\/10.1212\/WNL.0b013e3181fc27fa.","journal-title":"Neurology"},{"issue":"23","key":"453_CR69","doi-asserted-by":"publisher","first-page":"2207","DOI":"10.1212\/wnl.0000000000004012","volume":"88","author":"V Markovic","year":"2017","unstructured":"Markovic V, Agosta F, Canu E, Inuggi A, Petrovic I, Stankovic I, et al. Role of habenula and amygdala dysfunction in Parkinson disease patients with punding. Neurology. 2017;88(23):2207\u201315. https:\/\/doi.org\/10.1212\/wnl.0000000000004012.","journal-title":"Neurology"},{"issue":"12","key":"453_CR70","doi-asserted-by":"publisher","first-page":"984","DOI":"10.1016\/j.biopsych.2018.04.011","volume":"83","author":"MN Potenza","year":"2018","unstructured":"Potenza MN. Searching for replicable dopamine-related findings in gambling disorder. Biol Psychiat. 2018;83(12):984\u20136. https:\/\/doi.org\/10.1016\/j.biopsych.2018.04.011.","journal-title":"Biol Psychiat"},{"issue":"18","key":"453_CR71","doi-asserted-by":"publisher","first-page":"2139","DOI":"10.2174\/092986706777935258","volume":"13","author":"PH Elsinga","year":"2006","unstructured":"Elsinga PH, Hatano K, Ishiwata K. PET tracers for imaging of the dopaminergic system. Curr Med Chem. 2006;13(18):2139\u201353. https:\/\/doi.org\/10.2174\/092986706777935258.","journal-title":"Curr Med Chem"},{"issue":"2","key":"453_CR72","doi-asserted-by":"publisher","first-page":"400","DOI":"10.3906\/sag-2008-253","volume":"51","author":"\u00dc Akdemir","year":"2021","unstructured":"Akdemir \u00dc, Bora Tok\u00e7aer A, Atay L. Dopamine transporter SPECT imaging in Parkinson\u2019s disease and parkinsonian disorders. Turk J Med Sci. 2021;51(2):400\u201310. https:\/\/doi.org\/10.3906\/sag-2008-253.","journal-title":"Turk J Med Sci."},{"issue":"12","key":"453_CR73","doi-asserted-by":"publisher","first-page":"1036","DOI":"10.1016\/j.biopsych.2017.06.010","volume":"83","author":"RJ van Holst","year":"2018","unstructured":"van Holst RJ, Sescousse G, Janssen LK, Janssen M, Berry AS, Jagust WJ, et al. Increased striatal dopamine synthesis capacity in gambling addiction. Biol Psychiat. 2018;83(12):1036\u201343. https:\/\/doi.org\/10.1016\/j.biopsych.2017.06.010.","journal-title":"Biol Psychiat"},{"issue":"Pt 4","key":"453_CR74","doi-asserted-by":"publisher","first-page":"969","DOI":"10.1093\/brain\/awr003","volume":"134","author":"SS O'Sullivan","year":"2011","unstructured":"O\u2019Sullivan SS, Wu K, Politis M, Lawrence AD, Evans AH, Bose SK, et al. Cue-induced striatal dopamine release in Parkinson\u2019s disease-associated impulsive-compulsive behaviours. Brain J Neurol. 2011;134(Pt 4):969\u201378. https:\/\/doi.org\/10.1093\/brain\/awr003.","journal-title":"Brain J Neurol."},{"issue":"6","key":"453_CR75","doi-asserted-by":"publisher","first-page":"1504","DOI":"10.1007\/s00415-015-7722-7","volume":"262","author":"K Wu","year":"2015","unstructured":"Wu K, Politis M, O\u2019Sullivan SS, Lawrence AD, Warsi S, Bose S, et al. Single versus multiple impulse control disorders in Parkinson\u2019s disease: an 11C-raclopride positron emission tomography study of reward cue-evoked striatal dopamine release. J Neurol. 2015;262(6):1504\u201314. https:\/\/doi.org\/10.1007\/s00415-015-7722-7.","journal-title":"J Neurol"},{"issue":"1","key":"453_CR76","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1111\/j.1467-9450.2010.00837.x","volume":"52","author":"J Linnet","year":"2011","unstructured":"Linnet J, M\u00f8ller A, Peterson E, Gjedde A, Doudet D. Inverse association between dopaminergic neurotransmission and Iowa Gambling Task performance in pathological gamblers and healthy controls. Scand J Psychol. 2011;52(1):28\u201334. https:\/\/doi.org\/10.1111\/j.1467-9450.2010.00837.x.","journal-title":"Scand J Psychol"},{"issue":"2","key":"453_CR77","doi-asserted-by":"publisher","first-page":"383","DOI":"10.1111\/j.1360-0443.2010.03126.x","volume":"106","author":"J Linnet","year":"2011","unstructured":"Linnet J, M\u00f8ller A, Peterson E, Gjedde A, Doudet D. Dopamine release in ventral striatum during Iowa Gambling Task performance is associated with increased excitement levels in pathological gambling. Addiction (Abingdon, England). 2011;106(2):383\u201390. https:\/\/doi.org\/10.1111\/j.1360-0443.2010.03126.x.","journal-title":"Addiction (Abingdon, England)."},{"issue":"4","key":"453_CR78","doi-asserted-by":"publisher","first-page":"1992","DOI":"10.1016\/j.neuroimage.2012.02.006","volume":"60","author":"J Joutsa","year":"2012","unstructured":"Joutsa J, Johansson J, Niemel\u00e4 S, Ollikainen A, Hirvonen MM, Piepponen P, et al. Mesolimbic dopamine release is linked to symptom severity in pathological gambling. Neuroimage. 2012;60(4):1992\u20139. https:\/\/doi.org\/10.1016\/j.neuroimage.2012.02.006.","journal-title":"Neuroimage"},{"issue":"1","key":"453_CR79","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.neuroimage.2012.06.067","volume":"63","author":"L Clark","year":"2012","unstructured":"Clark L, Stokes PR, Wu K, Michalczuk R, Benecke A, Watson BJ, et al. Striatal dopamine D2\/D3 receptor binding in pathological gambling is correlated with mood-related impulsivity. Neuroimage. 2012;63(1):40\u20136. https:\/\/doi.org\/10.1016\/j.neuroimage.2012.06.067.","journal-title":"Neuroimage"},{"issue":"5","key":"453_CR80","doi-asserted-by":"publisher","first-page":"953","DOI":"10.1111\/add.12066","volume":"108","author":"I Boileau","year":"2013","unstructured":"Boileau I, Payer D, Chugani B, Lobo D, Behzadi A, Rusjan PM, et al. The D2\/3 dopamine receptor in pathological gambling: a positron emission tomography study with [11C]-(+)-propyl-hexahydro-naphtho-oxazin and [11C]raclopride. Addiction (Abingdon, England). 2013;108(5):953\u201363. https:\/\/doi.org\/10.1111\/add.12066.","journal-title":"Addiction (Abingdon, England)."},{"issue":"2","key":"453_CR81","doi-asserted-by":"publisher","first-page":"160","DOI":"10.1002\/mds.26135","volume":"30","author":"DE Payer","year":"2015","unstructured":"Payer DE, Guttman M, Kish SJ, Tong J, Strafella A, Zack M, et al. [11C]-(+)-PHNO PET imaging of dopamine D(2\/3) receptors in Parkinson\u2019s disease with impulse control disorders. Mov Disord. 2015;30(2):160\u20136. https:\/\/doi.org\/10.1002\/mds.26135.","journal-title":"Mov Disord."},{"issue":"3","key":"453_CR82","doi-asserted-by":"publisher","first-page":"519","DOI":"10.1016\/j.nbd.2012.06.021","volume":"48","author":"NJ Ray","year":"2012","unstructured":"Ray NJ, Miyasaki JM, Zurowski M, Ko JH, Cho SS, Pellecchia G, et al. Extrastriatal dopaminergic abnormalities of DA homeostasis in Parkinson\u2019s patients with medication-induced pathological gambling: a [11C] FLB-457 and PET study. Neurobiol Dis. 2012;48(3):519\u201325. https:\/\/doi.org\/10.1016\/j.nbd.2012.06.021.","journal-title":"Neurobiol Dis"},{"issue":"13","key":"453_CR83","doi-asserted-by":"publisher","first-page":"3230","DOI":"10.1523\/jneurosci.3082-17.2018","volume":"38","author":"AJ Stark","year":"2018","unstructured":"Stark AJ, Smith CT, Lin YC, Petersen KJ, Trujillo P, van Wouwe NC, et al. Nigrostriatal and mesolimbic D(2\/3) receptor expression in Parkinson\u2019s disease patients with compulsive reward-driven behaviors. J Neurosci. 2018;38(13):3230\u20139. https:\/\/doi.org\/10.1523\/jneurosci.3082-17.2018.","journal-title":"J Neurosci"},{"issue":"1","key":"453_CR84","doi-asserted-by":"publisher","DOI":"10.1038\/tp.2014.133","volume":"5","author":"J Joutsa","year":"2015","unstructured":"Joutsa J, Voon V, Johansson J, Niemel\u00e4 S, Bergman J, Kaasinen V. Dopaminergic function and intertemporal choice. Transl Psychiatry. 2015;5(1): e491. https:\/\/doi.org\/10.1038\/tp.2014.133.","journal-title":"Transl Psychiatry"},{"issue":"7","key":"453_CR85","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1002\/mds.25886","volume":"29","author":"C Vriend","year":"2014","unstructured":"Vriend C, Nordbeck AH, Booij J, van der Werf YD, Pattij T, Voorn P, et al. Reduced dopamine transporter binding predates impulse control disorders in Parkinson\u2019s disease. Mov Disord. 2014;29(7):904\u201311. https:\/\/doi.org\/10.1002\/mds.25886.","journal-title":"Mov Disord."},{"issue":"2","key":"453_CR86","doi-asserted-by":"publisher","first-page":"148","DOI":"10.1136\/jnnp-2013-305395","volume":"85","author":"V Voon","year":"2014","unstructured":"Voon V, Rizos A, Chakravartty R, Mulholland N, Robinson S, Howell NA, et al. Impulse control disorders in Parkinson\u2019s disease: decreased striatal dopamine transporter levels. J Neurol Neurosurg Psychiatry. 2014;85(2):148\u201352. https:\/\/doi.org\/10.1136\/jnnp-2013-305395.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"453_CR87","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1136\/jnnp-2013-305549","volume":"85","author":"JY Lee","year":"2014","unstructured":"Lee JY, Seo SH, Kim YK, Yoo HB, Kim YE, Song IC, et al. Extrastriatal dopaminergic changes in Parkinson\u2019s disease patients with impulse control disorders. J Neurol Neurosurg Psychiatry. 2014;85(1):23\u201330. https:\/\/doi.org\/10.1136\/jnnp-2013-305549.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"453_CR88","doi-asserted-by":"publisher","first-page":"864","DOI":"10.1136\/jnnp-2015-311827","volume":"87","author":"KM Smith","year":"2016","unstructured":"Smith KM, Xie SX, Weintraub D. Incident impulse control disorder symptoms and dopamine transporter imaging in Parkinson disease. J Neurol Neurosurg Psychiatry. 2016;87(8):864\u201370. https:\/\/doi.org\/10.1136\/jnnp-2015-311827.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"1","key":"453_CR89","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1176\/appi.ajp.2018.18040465","volume":"176","author":"D Weintraub","year":"2019","unstructured":"Weintraub D, Mamikonyan E. Impulse control disorders in Parkinson\u2019s disease. Am J Psychiatry. 2019;176(1):5\u201311. https:\/\/doi.org\/10.1176\/appi.ajp.2018.18040465.","journal-title":"Am J Psychiatry"},{"issue":"4","key":"453_CR90","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1007\/s00429-011-0314-0","volume":"216","author":"R Cilia","year":"2011","unstructured":"Cilia R, van Eimeren T. Impulse control disorders in Parkinson\u2019s disease: seeking a roadmap toward a better understanding. Brain Struct Funct. 2011;216(4):289\u201399. https:\/\/doi.org\/10.1007\/s00429-011-0314-0.","journal-title":"Brain Struct Funct"},{"issue":"3","key":"453_CR91","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.parkreldis.2009.12.002","volume":"16","author":"JY Lee","year":"2010","unstructured":"Lee JY, Kim JM, Kim JW, Cho J, Lee WY, Kim HJ, et al. Association between the dose of dopaminergic medication and the behavioral disturbances in Parkinson disease. Parkinsonism Relat Disord. 2010;16(3):202\u20137. https:\/\/doi.org\/10.1016\/j.parkreldis.2009.12.002.","journal-title":"Parkinsonism Relat Disord"},{"issue":"3","key":"453_CR92","first-page":"141","volume":"21","author":"MF Piercey","year":"1998","unstructured":"Piercey MF. Pharmacology of pramipexole, a dopamine D3-preferring agonist useful in treating Parkinson\u2019s disease. Clin Neuropharmacol. 1998;21(3):141\u201351.","journal-title":"Clin Neuropharmacol"},{"issue":"3","key":"453_CR93","doi-asserted-by":"publisher","first-page":"253","DOI":"10.1111\/j.1527-3458.2005.tb00046.x","volume":"11","author":"WH Jost","year":"2005","unstructured":"Jost WH, Angersbach D. Ropinirole, a non-ergoline dopamine agonist. CNS Drug Rev. 2005;11(3):253\u201372. https:\/\/doi.org\/10.1111\/j.1527-3458.2005.tb00046.x.","journal-title":"CNS Drug Rev"},{"issue":"4","key":"453_CR94","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1002\/syn.21805","volume":"69","author":"P Seeman","year":"2015","unstructured":"Seeman P. Parkinson\u2019s disease treatment may cause impulse-control disorder via dopamine D3 receptors. Synapse (New York, NY). 2015;69(4):183\u20139. https:\/\/doi.org\/10.1002\/syn.21805.","journal-title":"Synapse (New York, NY)."},{"key":"453_CR95","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neuropharm.2012.12.011","volume":"70","author":"Y Zengin-Toktas","year":"2013","unstructured":"Zengin-Toktas Y, Authier N, Denizot H, Chassain C, Hafidi A, Llorca PM, et al. Motivational properties of D2 and D3 dopamine receptors agonists and cocaine, but not with D1 dopamine receptors agonist and L-dopa, in bilateral 6-OHDA-lesioned rat. Neuropharmacology. 2013;70:74\u201382. https:\/\/doi.org\/10.1016\/j.neuropharm.2012.12.011.","journal-title":"Neuropharmacology"},{"issue":"5","key":"453_CR96","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1097\/WNF.0b013e3182281b2f","volume":"34","author":"J Martinkova","year":"2011","unstructured":"Martinkova J, Trejbalova L, Sasikova M, Benetin J, Valkovic P. Impulse control disorders associated with dopaminergic medication in patients with pituitary adenomas. Clin Neuropharmacol. 2011;34(5):179\u201381. https:\/\/doi.org\/10.1097\/WNF.0b013e3182281b2f.","journal-title":"Clin Neuropharmacol"},{"key":"453_CR97","unstructured":"U.S. Food and Drug Administration. FDA Drug Safety Communication: FDA warns about new impulse-control problems associated with mental health drug aripiprazole (Abilify, Abilify Maintena, Aristada). U.S. Food and Drug Administration, 2016. https:\/\/www.fda.gov\/drugs\/drug-safety-and-availability\/fda-drug-safety-communication-fda-warns-about-new-impulse-control-problems-associated-mental-health."},{"issue":"8","key":"453_CR98","doi-asserted-by":"publisher","first-page":"1192","DOI":"10.2174\/1570159x15666170413115754","volume":"15","author":"EW Tuplin","year":"2017","unstructured":"Tuplin EW, Holahan MR. Aripiprazole, a drug that displays partial agonism and functional selectivity. Curr Neuropharmacol. 2017;15(8):1192\u2013207. https:\/\/doi.org\/10.2174\/1570159x15666170413115754.","journal-title":"Curr Neuropharmacol"},{"issue":"3","key":"453_CR99","doi-asserted-by":"publisher","first-page":"101","DOI":"10.1097\/wnf.0000000000000342","volume":"42","author":"HY Chen","year":"2019","unstructured":"Chen HY, Ma CH, Liu CC. Two cases of de novo pathological gambling associated with aripiprazole. Clin Neuropharmacol. 2019;42(3):101\u20132. https:\/\/doi.org\/10.1097\/wnf.0000000000000342.","journal-title":"Clin Neuropharmacol"},{"key":"453_CR100","doi-asserted-by":"publisher","DOI":"10.7727\/wimj.2015.107","author":"M Ceylan","year":"2015","unstructured":"Ceylan M, Evrensel A, \u00dcnsalver B, C\u00f6mert G. Pathological gambling due to aripiprazole: two cases. West Indian Med J. 2015. https:\/\/doi.org\/10.7727\/wimj.2015.107.","journal-title":"West Indian Med J"},{"issue":"1","key":"453_CR101","doi-asserted-by":"publisher","first-page":"102","DOI":"10.1097\/jcp.0000000000000634","volume":"37","author":"M Etminan","year":"2017","unstructured":"Etminan M, Sodhi M, Samii A, Procyshyn RM, Guo M, Carleton BC. Risk of gambling disorder and impulse control disorder with aripiprazole, pramipexole, and ropinirole: a pharmacoepidemiologic study. J Clin Psychopharmacol. 2017;37(1):102\u20134. https:\/\/doi.org\/10.1097\/jcp.0000000000000634.","journal-title":"J Clin Psychopharmacol"},{"issue":"6","key":"453_CR102","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0252516","volume":"16","author":"M Wolfschlag","year":"2021","unstructured":"Wolfschlag M, H\u00e5kansson A. Increased risk for developing gambling disorder under the treatment with pramipexole, ropinirole, and aripiprazole: a nationwide register study in Sweden. PLoS ONE. 2021;16(6): e0252516. https:\/\/doi.org\/10.1371\/journal.pone.0252516.","journal-title":"PLoS ONE"},{"issue":"2","key":"453_CR103","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1097\/jcp.0000000000000846","volume":"38","author":"R Menon","year":"2018","unstructured":"Menon R, Cribb L, Sarris J, Ng CH. A case of acute problem gambling associated with agomelatine. J Clin Psychopharmacol. 2018;38(2):153\u20135. https:\/\/doi.org\/10.1097\/jcp.0000000000000846.","journal-title":"J Clin Psychopharmacol"},{"issue":"9","key":"453_CR104","doi-asserted-by":"publisher","first-page":"28","DOI":"10.17116\/jnevro20151159128-31","volume":"115","author":"AY Egorov","year":"2015","unstructured":"Egorov AY. The use of agomelatine (valdoxan) in gambling therapy: a pilot study. Zh Nevrol Psikhiatr Im S S Korsakova. 2015;115(9):28\u201331. https:\/\/doi.org\/10.17116\/jnevro20151159128-31.","journal-title":"Zh Nevrol Psikhiatr Im S S Korsakova"},{"issue":"5\u20136","key":"453_CR105","doi-asserted-by":"publisher","first-page":"474","DOI":"10.1097\/FBP.0b013e3283305e65","volume":"20","author":"I Tsutsui-Kimura","year":"2009","unstructured":"Tsutsui-Kimura I, Ohmura Y, Izumi T, Yamaguchi T, Yoshida T, Yoshioka M. The effects of serotonin and\/or noradrenaline reuptake inhibitors on impulsive-like action assessed by the three-choice serial reaction time task: a simple and valid model of impulsive action using rats. Behav Pharmacol. 2009;20(5\u20136):474\u201383. https:\/\/doi.org\/10.1097\/FBP.0b013e3283305e65.","journal-title":"Behav Pharmacol"},{"issue":"8","key":"453_CR106","doi-asserted-by":"publisher","first-page":"740","DOI":"10.1016\/j.biopsych.2014.01.024","volume":"77","author":"Z Ye","year":"2015","unstructured":"Ye Z, Altena E, Nombela C, Housden CR, Maxwell H, Rittman T, et al. Improving response inhibition in Parkinson\u2019s disease with atomoxetine. Biol Psychiatry. 2015;77(8):740\u20138. https:\/\/doi.org\/10.1016\/j.biopsych.2014.01.024.","journal-title":"Biol Psychiatry"},{"issue":"8","key":"453_CR107","doi-asserted-by":"publisher","first-page":"2235","DOI":"10.1093\/brain\/aww138","volume":"139","author":"CL Rae","year":"2016","unstructured":"Rae CL, Nombela C, Rodr\u00edguez PV, Ye Z, Hughes LE, Jones PS, et al. Atomoxetine restores the response inhibition network in Parkinson\u2019s disease. Brain J Neurol. 2016;139(8):2235\u201348. https:\/\/doi.org\/10.1093\/brain\/aww138.","journal-title":"Brain J Neurol."},{"issue":"3","key":"453_CR108","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1002\/mdc3.12455","volume":"4","author":"VK Hinson","year":"2017","unstructured":"Hinson VK, Delambo A, Elm J, Turner T. A randomized clinical trial of atomoxetine for mild cognitive impairment in Parkinson\u2019s disease. Mov Disord Clin Pract. 2017;4(3):416\u201323. https:\/\/doi.org\/10.1002\/mdc3.12455.","journal-title":"Mov Disord Clin Pract."},{"key":"453_CR109","doi-asserted-by":"publisher","first-page":"164","DOI":"10.1016\/j.neuroimage.2013.08.001","volume":"86","author":"YS Ding","year":"2014","unstructured":"Ding YS, Naganawa M, Gallezot JD, Nabulsi N, Lin SF, Ropchan J, et al. Clinical doses of atomoxetine significantly occupy both norepinephrine and serotonin transports: implications on treatment of depression and ADHD. Neuroimage. 2014;86:164\u201371. https:\/\/doi.org\/10.1016\/j.neuroimage.2013.08.001.","journal-title":"Neuroimage"},{"key":"453_CR110","doi-asserted-by":"publisher","first-page":"8470045","DOI":"10.1155\/2021\/8470045","volume":"2021","author":"K Sakurada","year":"2021","unstructured":"Sakurada K, Nibuya M, Yamada K, Nakagawa S, Suzuki E. Kleptomania induced by venlafaxine. Case Rep Psychiatry. 2021;2021:8470045. https:\/\/doi.org\/10.1155\/2021\/8470045.","journal-title":"Case Rep Psychiatry."},{"issue":"2","key":"453_CR111","doi-asserted-by":"publisher","first-page":"241","DOI":"10.1111\/j.1440-1819.2008.01763.x","volume":"62","author":"G Camardese","year":"2008","unstructured":"Camardese G, Picello A, Bria P. Venlafaxine: successful treatment in impulsive disorders. Psychiatry Clin Neurosci. 2008;62(2):241\u20132. https:\/\/doi.org\/10.1111\/j.1440-1819.2008.01763.x.","journal-title":"Psychiatry Clin Neurosci"},{"key":"453_CR112","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/j.neuropharm.2013.05.015","volume":"73","author":"K Smart","year":"2013","unstructured":"Smart K, Desmond RC, Poulos CX, Zack M. Modafinil increases reward salience in a slot machine game in low and high impulsivity pathological gamblers. Neuropharmacology. 2013;73:66\u201374. https:\/\/doi.org\/10.1016\/j.neuropharm.2013.05.015.","journal-title":"Neuropharmacology"},{"issue":"1","key":"453_CR113","doi-asserted-by":"publisher","first-page":"195","DOI":"10.1038\/sj.npp.1300333","volume":"29","author":"M Zack","year":"2004","unstructured":"Zack M, Poulos CX. Amphetamine primes motivation to gamble and gambling-related semantic networks in problem gamblers. Neuropsychopharmacology. 2004;29(1):195\u2013207. https:\/\/doi.org\/10.1038\/sj.npp.1300333.","journal-title":"Neuropsychopharmacology"},{"issue":"12","key":"453_CR114","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1038\/mp.2013.163","volume":"19","author":"I Boileau","year":"2014","unstructured":"Boileau I, Payer D, Chugani B, Lobo DS, Houle S, Wilson AA, et al. In vivo evidence for greater amphetamine-induced dopamine release in pathological gambling: a positron emission tomography study with [(11)C]-(+)-PHNO. Mol Psychiatry. 2014;19(12):1305\u201313. https:\/\/doi.org\/10.1038\/mp.2013.163.","journal-title":"Mol Psychiatry"},{"issue":"8","key":"453_CR115","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1038\/sj.npp.1301295","volume":"32","author":"M Zack","year":"2007","unstructured":"Zack M, Poulos CX. A D2 antagonist enhances the rewarding and priming effects of a gambling episode in pathological gamblers. Neuropsychopharmacology. 2007;32(8):1678\u201386. https:\/\/doi.org\/10.1038\/sj.npp.1301295.","journal-title":"Neuropsychopharmacology"},{"issue":"3","key":"453_CR116","doi-asserted-by":"publisher","first-page":"467","DOI":"10.1111\/j.1369-1600.2010.00208.x","volume":"16","author":"AM Tremblay","year":"2011","unstructured":"Tremblay AM, Desmond RC, Poulos CX, Zack M. Haloperidol modifies instrumental aspects of slot machine gambling in pathological gamblers and healthy controls. Addict Biol. 2011;16(3):467\u201384. https:\/\/doi.org\/10.1111\/j.1369-1600.2010.00208.x.","journal-title":"Addict Biol"},{"issue":"3","key":"453_CR117","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.pbb.2007.12.025","volume":"89","author":"T Fong","year":"2008","unstructured":"Fong T, Kalechstein A, Bernhard B, Rosenthal R, Rugle L. A double-blind, placebo-controlled trial of olanzapine for the treatment of video poker pathological gamblers. Pharmacol Biochem Behav. 2008;89(3):298\u2013303. https:\/\/doi.org\/10.1016\/j.pbb.2007.12.025.","journal-title":"Pharmacol Biochem Behav"},{"issue":"3","key":"453_CR118","doi-asserted-by":"publisher","first-page":"433","DOI":"10.4088\/jcp.v69n0314","volume":"69","author":"SL McElroy","year":"2008","unstructured":"McElroy SL, Nelson EB, Welge JA, Kaehler L, Keck PE Jr. Olanzapine in the treatment of pathological gambling: a negative randomized placebo-controlled trial. J Clin Psychiatry. 2008;69(3):433\u201340. https:\/\/doi.org\/10.4088\/jcp.v69n0314.","journal-title":"J Clin Psychiatry"},{"issue":"9","key":"453_CR119","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1016\/j.jagp.2019.03.002","volume":"27","author":"D Weintraub","year":"2019","unstructured":"Weintraub D, Mamikonyan E. The neuropsychiatry of parkinson disease: a perfect storm. Am J Geriatr Psychiatry. 2019;27(9):998\u20131018. https:\/\/doi.org\/10.1016\/j.jagp.2019.03.002.","journal-title":"Am J Geriatr Psychiatry"},{"issue":"4","key":"453_CR120","doi-asserted-by":"publisher","first-page":"342","DOI":"10.1212\/01.wnl.0000268695.63392.10","volume":"69","author":"B Ravina","year":"2007","unstructured":"Ravina B, Camicioli R, Como PG, Marsh L, Jankovic J, Weintraub D, et al. The impact of depressive symptoms in early Parkinson disease. Neurology. 2007;69(4):342\u20137. https:\/\/doi.org\/10.1212\/01.wnl.0000268695.63392.10.","journal-title":"Neurology"},{"issue":"4","key":"453_CR121","doi-asserted-by":"publisher","first-page":"447","DOI":"10.1002\/mds.27668","volume":"34","author":"D Weintraub","year":"2019","unstructured":"Weintraub D. Impulse control disorders in Parkinson\u2019s disease: a 20-year odyssey. Mov Disord. 2019;34(4):447\u201352. https:\/\/doi.org\/10.1002\/mds.27668.","journal-title":"Mov Disord."},{"key":"453_CR122","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpsychores.2019.109884","volume":"128","author":"PJ Tully","year":"2020","unstructured":"Tully PJ, Kurth T, Elbaz A, Tzourio C. Convergence of psychiatric symptoms and restless legs syndrome: a cross-sectional study in an elderly French population. J Psychosom Res. 2020;128: 109884. https:\/\/doi.org\/10.1016\/j.jpsychores.2019.109884.","journal-title":"J Psychosom Res"},{"issue":"8","key":"453_CR123","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.4088\/JCP.v68n0810","volume":"68","author":"CB Aiken","year":"2007","unstructured":"Aiken CB. Pramipexole in psychiatry: a systematic review of the literature. J Clin Psychiatry. 2007;68(8):1230\u20136.","journal-title":"J Clin Psychiatry"},{"issue":"3","key":"453_CR124","doi-asserted-by":"publisher","first-page":"425","DOI":"10.1007\/s10899-009-9123-2","volume":"25","author":"AJ Holman","year":"2009","unstructured":"Holman AJ. Impulse control disorder behaviors associated with pramipexole used to treat fibromyalgia. J Gambl Stud. 2009;25(3):425\u201331. https:\/\/doi.org\/10.1007\/s10899-009-9123-2.","journal-title":"J Gambl Stud"},{"key":"453_CR125","doi-asserted-by":"publisher","first-page":"214","DOI":"10.3389\/fpsyt.2017.00214","volume":"8","author":"A Sauvaget","year":"2017","unstructured":"Sauvaget A, Jim\u00e9nez-Murcia S, Fern\u00e1ndez-Aranda F, Granero R, Grall-Bronnec M, Victorri-Vigneau C, et al. A comparison of treatment-seeking behavioral addiction patients with and without Parkinson\u2019s disease. Front Psych. 2017;8:214. https:\/\/doi.org\/10.3389\/fpsyt.2017.00214.","journal-title":"Front Psych"},{"key":"453_CR126","doi-asserted-by":"publisher","DOI":"10.1016\/j.psychres.2021.114142","volume":"304","author":"A Vita","year":"2021","unstructured":"Vita A, Bastiani L, Turrina C, Benedetti E, Bergamini A, Molinaro S. At-risk gambling in patients with severe psychiatric illness and in community subjects matched for age and sex. Psychiatry Res. 2021;304: 114142. https:\/\/doi.org\/10.1016\/j.psychres.2021.114142.","journal-title":"Psychiatry Res"},{"key":"453_CR127","doi-asserted-by":"publisher","DOI":"10.1016\/j.pnpbp.2021.110389","volume":"111","author":"M Brodeur","year":"2021","unstructured":"Brodeur M, Audette-Chapdelaine S, Savard AC, Kairouz S. Gambling and the COVID-19 pandemic: a scoping review. Prog Neuropsychopharmacol Biol Psychiatry. 2021;111: 110389. https:\/\/doi.org\/10.1016\/j.pnpbp.2021.110389.","journal-title":"Prog Neuropsychopharmacol Biol Psychiatry"},{"issue":"6","key":"453_CR128","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1159\/000337442","volume":"18","author":"S Jim\u00e9nez-Murcia","year":"2012","unstructured":"Jim\u00e9nez-Murcia S, Bove FI, Israel M, Steiger H, Fern\u00e1ndez-Aranda F, Alvarez-Moya E, et al. Cognitive-behavioral therapy for pathological gambling in Parkinson\u2019s disease: a pilot controlled study. Eur Addict Res. 2012;18(6):265\u201374. https:\/\/doi.org\/10.1159\/000337442.","journal-title":"Eur Addict Res"},{"issue":"4","key":"453_CR129","doi-asserted-by":"publisher","first-page":"e15","DOI":"10.1097\/adm.0000000000000574","volume":"14","author":"M Di Nicola","year":"2020","unstructured":"Di Nicola M, De Crescenzo F, D\u2019Al\u00f2 GL, Remondi C, Panaccione I, Moccia L, et al. Pharmacological and psychosocial treatment of adults with gambling disorder: a meta-review. J Addict Med. 2020;14(4):e15\u201323. https:\/\/doi.org\/10.1097\/adm.0000000000000574.","journal-title":"J Addict Med"},{"key":"453_CR130","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD008937.pub2","volume":"11","author":"S Cowlishaw","year":"2012","unstructured":"Cowlishaw S, Merkouris S, Dowling N, Anderson C, Jackson A, Thomas S. Psychological therapies for pathological and problem gambling. Cochrane Database Syst Rev. 2012;11: CD008937. https:\/\/doi.org\/10.1002\/14651858.CD008937.pub2.","journal-title":"Cochrane Database Syst Rev"},{"issue":"2","key":"453_CR131","doi-asserted-by":"publisher","first-page":"415","DOI":"10.1007\/s10899-018-09815-y","volume":"35","author":"M Goslar","year":"2019","unstructured":"Goslar M, Leibetseder M, Muench HM, Hofmann SG, Laireiter AR. Pharmacological treatments for disordered gambling: a meta-analysis. J Gambl Stud. 2019;35(2):415\u201345. https:\/\/doi.org\/10.1007\/s10899-018-09815-y.","journal-title":"J Gambl Stud"},{"key":"453_CR132","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1016\/j.addbeh.2014.12.011","volume":"43","author":"I Yakovenko","year":"2015","unstructured":"Yakovenko I, Quigley L, Hemmelgarn BR, Hodgins DC, Ronksley P. The efficacy of motivational interviewing for disordered gambling: systematic review and meta-analysis. Addict Behav. 2015;43:72\u201382. https:\/\/doi.org\/10.1016\/j.addbeh.2014.12.011.","journal-title":"Addict Behav"},{"issue":"4","key":"453_CR133","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0214502","volume":"14","author":"LC Quilty","year":"2019","unstructured":"Quilty LC, Wardell JD, Thiruchselvam T, Keough MT, Hendershot CS. Brief interventions for problem gambling: a meta-analysis. PLoS ONE. 2019;14(4): e0214502. https:\/\/doi.org\/10.1371\/journal.pone.0214502.","journal-title":"PLoS ONE"},{"key":"453_CR134","doi-asserted-by":"publisher","first-page":"2344","DOI":"10.3389\/fpsyg.2017.02344","volume":"8","author":"J Tremblay","year":"2017","unstructured":"Tremblay J, Dufour M, Bertrand K, Blanchette-Martin N, Ferland F, Savard AC, et al. The experience of couples in the process of treatment of pathological gambling: couple vs. individual therapy. Front Psychol. 2017;8:2344. https:\/\/doi.org\/10.3389\/fpsyg.2017.02344.","journal-title":"Front Psychol"},{"issue":"1009","key":"453_CR135","doi-asserted-by":"publisher","first-page":"590","DOI":"10.1136\/pgmj.2008.075820","volume":"85","author":"K Wu","year":"2009","unstructured":"Wu K, Politis M, Piccini P. Parkinson disease and impulse control disorders: a review of clinical features, pathophysiology and management. Postgrad Med J. 2009;85(1009):590\u20136. https:\/\/doi.org\/10.1136\/pgmj.2008.075820.","journal-title":"Postgrad Med J"},{"issue":"2","key":"453_CR136","doi-asserted-by":"publisher","first-page":"189","DOI":"10.1007\/s40501-014-0014-5","volume":"1","author":"SW Yip","year":"2014","unstructured":"Yip SW, Potenza MN. Treatment of gambling disorders. Curr Treat Options Psychiatry. 2014;1(2):189\u2013203. https:\/\/doi.org\/10.1007\/s40501-014-0014-5.","journal-title":"Curr Treat Options Psychiatry."},{"issue":"9","key":"453_CR137","doi-asserted-by":"publisher","first-page":"826","DOI":"10.1212\/wnl.0000000000000729","volume":"83","author":"K Papay","year":"2014","unstructured":"Papay K, Xie SX, Stern M, Hurtig H, Siderowf A, Duda JE, et al. Naltrexone for impulse control disorders in Parkinson disease: a placebo-controlled study. Neurology. 2014;83(9):826\u201333. https:\/\/doi.org\/10.1212\/wnl.0000000000000729.","journal-title":"Neurology"},{"issue":"9","key":"453_CR138","doi-asserted-by":"publisher","first-page":"792","DOI":"10.1212\/WNL.0b013e3182840678","volume":"80","author":"D Okai","year":"2013","unstructured":"Okai D, Askey-Jones S, Samuel M, O\u2019Sullivan SS, Chaudhuri KR, Martin A, et al. Trial of CBT for impulse control behaviors affecting Parkinson patients and their caregivers. Neurology. 2013;80(9):792\u20139. https:\/\/doi.org\/10.1212\/WNL.0b013e3182840678.","journal-title":"Neurology"},{"key":"453_CR139","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1186\/s12991-016-0107-1","volume":"15","author":"SW Choi","year":"2016","unstructured":"Choi SW, Shin YC, Youn H, Lim SW, Ha J. Pharmacotherapy and group cognitive behavioral therapy enhance follow-up treatment duration in gambling disorder patients. Ann Gen Psychiatry. 2016;15:20. https:\/\/doi.org\/10.1186\/s12991-016-0107-1.","journal-title":"Ann Gen Psychiatry"},{"key":"453_CR140","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1007\/s11469-011-9335-4","volume":"10","author":"P Binde","year":"2012","unstructured":"Binde P. A Swedish mutual support society of problem gamblers. Int J Ment Heal Addict. 2012;10:1\u201312. https:\/\/doi.org\/10.1007\/s11469-011-9335-4.","journal-title":"Int J Ment Heal Addict"},{"issue":"2","key":"453_CR141","doi-asserted-by":"publisher","first-page":"367","DOI":"10.1007\/s10899-018-9777-8","volume":"35","author":"R Kotter","year":"2019","unstructured":"Kotter R, Kr\u00e4plin A, Pittig A, B\u00fchringer G. A systematic review of land-based self-exclusion programs: demographics, gambling behavior, gambling problems, mental symptoms, and mental health. J Gambl Stud. 2019;35(2):367\u201394. https:\/\/doi.org\/10.1007\/s10899-018-9777-8.","journal-title":"J Gambl Stud"},{"key":"453_CR142","doi-asserted-by":"publisher","DOI":"10.3389\/fpsyt.2020.599967","volume":"11","author":"A H\u00e5kansson","year":"2020","unstructured":"H\u00e5kansson A, Widinghoff C. Gambling despite nationwide self-exclusion\u2014a survey in online gamblers in Sweden. Front Psych. 2020;11: 599967. https:\/\/doi.org\/10.3389\/fpsyt.2020.599967.","journal-title":"Front Psych"},{"key":"453_CR143","doi-asserted-by":"publisher","first-page":"203","DOI":"10.3389\/fpsyg.2014.00203","volume":"5","author":"R van den Bos","year":"2014","unstructured":"van den Bos R, Koot S, de Visser L. A rodent version of the Iowa Gambling Task: 7 years of progress. Front Psychol. 2014;5:203. https:\/\/doi.org\/10.3389\/fpsyg.2014.00203.","journal-title":"Front Psychol"},{"issue":"1","key":"453_CR144","doi-asserted-by":"publisher","first-page":"123","DOI":"10.1007\/s00213-011-2382-5","volume":"219","author":"GT Collins","year":"2012","unstructured":"Collins GT, Cunningham AR, Chen J, Wang S, Newman AH, Woods JH. Effects of pramipexole on the reinforcing effectiveness of stimuli that were previously paired with cocaine reinforcement in rats. Psychopharmacology. 2012;219(1):123\u201335. https:\/\/doi.org\/10.1007\/s00213-011-2382-5.","journal-title":"Psychopharmacology"},{"issue":"3","key":"453_CR145","doi-asserted-by":"publisher","first-page":"327","DOI":"10.1002\/mds.25291","volume":"28","author":"J Bastiaens","year":"2013","unstructured":"Bastiaens J, Dorfman BJ, Christos PJ, Nirenberg MJ. Prospective cohort study of impulse control disorders in Parkinson\u2019s disease. Mov Disord. 2013;28(3):327\u201333. https:\/\/doi.org\/10.1002\/mds.25291.","journal-title":"Mov Disord."},{"issue":"5","key":"453_CR146","doi-asserted-by":"publisher","first-page":"691","DOI":"10.1097\/JCP.0b013e3182979830","volume":"33","author":"M Poletti","year":"2013","unstructured":"Poletti M, Logi C, Lucetti C, Del Dotto P, Baldacci F, Vergallo A, et al. A single-center, cross-sectional prevalence study of impulse control disorders in Parkinson disease: association with dopaminergic drugs. J Clin Psychopharmacol. 2013;33(5):691\u20134. https:\/\/doi.org\/10.1097\/JCP.0b013e3182979830.","journal-title":"J Clin Psychopharmacol"},{"issue":"8","key":"453_CR147","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1136\/jnnp-2013-306787","volume":"85","author":"PJ Garcia-Ruiz","year":"2014","unstructured":"Garcia-Ruiz PJ, Martinez Castrillo JC, Alonso-Canovas A, Herranz Barcenas A, Vela L, Sanchez Alonso P, et al. Impulse control disorder in patients with Parkinson\u2019s disease under dopamine agonist therapy: a multicentre study. J Neurol Neurosurg Psychiatry. 2014;85(8):840\u20134. https:\/\/doi.org\/10.1136\/jnnp-2013-306787.","journal-title":"J Neurol Neurosurg Psychiatry"},{"issue":"8","key":"453_CR148","doi-asserted-by":"publisher","first-page":"907","DOI":"10.1016\/j.parkreldis.2014.05.014","volume":"20","author":"M Rodr\u00edguez-Violante","year":"2014","unstructured":"Rodr\u00edguez-Violante M, Gonz\u00e1lez-Latapi P, Cervantes-Arriaga A, Camacho-Ordo\u00f1ez A, Weintraub D. Impulse control and related disorders in Mexican Parkinson\u2019s disease patients. Parkinsonism Relat Disord. 2014;20(8):907\u201310. https:\/\/doi.org\/10.1016\/j.parkreldis.2014.05.014.","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"453_CR149","doi-asserted-by":"publisher","first-page":"49","DOI":"10.4103\/0972-2327.144311","volume":"18","author":"A Sharma","year":"2015","unstructured":"Sharma A, Goyal V, Behari M, Srivastva A, Shukla G, Vibha D. Impulse control disorders and related behaviours (ICD-RBs) in Parkinson\u2019s disease patients: assessment using \u201cQuestionnaire for impulsive-compulsive disorders in Parkinson\u2019s disease\u201d (QUIP). Ann Indian Acad Neurol. 2015;18(1):49\u201359. https:\/\/doi.org\/10.4103\/0972-2327.144311.","journal-title":"Ann Indian Acad Neurol"},{"issue":"8","key":"453_CR150","doi-asserted-by":"publisher","first-page":"1255","DOI":"10.1111\/ene.13034","volume":"23","author":"A Rizos","year":"2016","unstructured":"Rizos A, Sauerbier A, Antonini A, Weintraub D, Martinez-Martin P, Kessel B, et al. A European multicentre survey of impulse control behaviours in Parkinson\u2019s disease patients treated with short- and long-acting dopamine agonists. Eur J Neurol. 2016;23(8):1255\u201361. https:\/\/doi.org\/10.1111\/ene.13034.","journal-title":"Eur J Neurol"},{"issue":"1","key":"453_CR151","doi-asserted-by":"publisher","first-page":"183","DOI":"10.3233\/jpd-160977","volume":"7","author":"AH Erga","year":"2017","unstructured":"Erga AH, Alves G, Larsen JP, Tysnes OB, Pedersen KF. Impulsive and compulsive behaviors in Parkinson\u2019s disease: the Norwegian Parkwest study. J Parkinsons Dis. 2017;7(1):183\u201391. https:\/\/doi.org\/10.3233\/jpd-160977.","journal-title":"J Parkinsons Dis"},{"issue":"3","key":"453_CR152","doi-asserted-by":"publisher","first-page":"e189","DOI":"10.1212\/wnl.0000000000005816","volume":"91","author":"JC Corvol","year":"2018","unstructured":"Corvol JC, Artaud F, Cormier-Dequaire F, Rascol O, Durif F, Derkinderen P, et al. Longitudinal analysis of impulse control disorders in Parkinson disease. Neurology. 2018;91(3):e189\u2013201. https:\/\/doi.org\/10.1212\/wnl.0000000000005816.","journal-title":"Neurology"},{"issue":"4","key":"453_CR153","doi-asserted-by":"publisher","first-page":"233","DOI":"10.1016\/j.neurol.2018.07.009","volume":"175","author":"H El Otmani","year":"2019","unstructured":"El Otmani H, Mouni FZ, Abdulhakeem Z, Attar Z, Rashad L, Saali I, et al. Impulse control disorders in Parkinson disease: a cross-sectional study in Morocco. Revue neurologique. 2019;175(4):233\u20137. https:\/\/doi.org\/10.1016\/j.neurol.2018.07.009.","journal-title":"Revue neurologique."},{"key":"453_CR154","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.parkreldis.2019.06.019","volume":"68","author":"AP Vargas","year":"2019","unstructured":"Vargas AP, Vaz LS, Reuter A, Couto CM, Costa Cardoso FE. Impulse control symptoms in patients with Parkinson\u2019s disease: the influence of dopaminergic agonist. Parkinsonism Relat Disord. 2019;68:17\u201321. https:\/\/doi.org\/10.1016\/j.parkreldis.2019.06.019.","journal-title":"Parkinsonism Relat Disord"},{"issue":"1","key":"453_CR155","first-page":"81","volume":"33","author":"JR Cornelius","year":"2010","unstructured":"Cornelius JR, Tippmann-Peikert M, Slocumb NL, Frerichs CF, Silber MH. Impulse control disorders with the use of dopaminergic agents in restless legs syndrome: a case-control study. Sleep. 2010;33(1):81\u20137.","journal-title":"Sleep"},{"issue":"12","key":"453_CR156","doi-asserted-by":"publisher","first-page":"1930","DOI":"10.1001\/jamainternmed.2014.5262","volume":"174","author":"TJ Moore","year":"2014","unstructured":"Moore TJ, Glenmullen J, Mattison DR. Reports of pathological gambling, hypersexuality, and compulsive shopping associated with dopamine receptor agonist drugs. JAMA Intern Med. 2014;174(12):1930\u20133. https:\/\/doi.org\/10.1001\/jamainternmed.2014.5262.","journal-title":"JAMA Intern Med"},{"key":"453_CR157","doi-asserted-by":"publisher","first-page":"593","DOI":"10.1016\/j.psychres.2018.09.008","volume":"269","author":"PF Lanteri","year":"2018","unstructured":"Lanteri PF, Leguia A, Dolad\u00e9 NG, Garc\u00eda GC, Figueras A. Drug-induced gambling disorder: a not so rare but underreported condition. Psychiatry Res. 2018;269:593\u20135. https:\/\/doi.org\/10.1016\/j.psychres.2018.09.008.","journal-title":"Psychiatry Res"},{"issue":"1","key":"453_CR158","doi-asserted-by":"publisher","first-page":"85","DOI":"10.1007\/s10899-019-09828-1","volume":"36","author":"C Scavone","year":"2020","unstructured":"Scavone C, Stelitano B, Rafaniello C, Rossi F, Sportiello L, Capuano A. Drugs-induced pathological gambling: an analysis of Italian spontaneous reporting system. J Gambl Stud. 2020;36(1):85\u201396. https:\/\/doi.org\/10.1007\/s10899-019-09828-1.","journal-title":"J Gambl Stud"}],"container-title":["Pharmaceutical Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40290-022-00453-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s40290-022-00453-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s40290-022-00453-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T14:16:13Z","timestamp":1674656173000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s40290-022-00453-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1]]},"references-count":158,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["453"],"URL":"https:\/\/doi.org\/10.1007\/s40290-022-00453-9","relation":{},"ISSN":["1178-2595","1179-1993"],"issn-type":[{"value":"1178-2595","type":"print"},{"value":"1179-1993","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"8 November 2022","order":1,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"7 January 2023","order":2,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Open access funding provided by Lund University. Anders H\u00e5kansson has a position at Lund University that is sponsored by the state-owned gambling operator AB Svenska Spel, and he has funding acquired from the research council of Svenska Spel. Mirjam Wolfschlag is part of H\u00e5kansson\u2019s research group and has obtained funding from the research council of Svenska Spel. H\u00e5kansson\u2019s time invested in the present research is thereby supported by the position sponsored by Svenska Spel, although no specific funding has been obtained for the present study. No other organization than the authors themselves were involved in the idea or content of the present paper.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Funding"}},{"value":"The authors declare no other conflicts of interest besides the ones mentioned in the Funding declaration.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflicts of interest\/competing interest"}},{"value":"Not applicable.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval"}},{"value":"Not applicable.","order":5,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent to participate"}},{"value":"Not applicable.","order":6,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"Not applicable.","order":7,"name":"Ethics","group":{"name":"EthicsHeading","label":"Availability of data and material"}},{"value":"Not applicable.","order":8,"name":"Ethics","group":{"name":"EthicsHeading","label":"Code availability"}},{"value":"AH and MW contributed equally to this review article regarding the literature search and writing the manuscript. All authors have read and approved the final submitted manuscript and agree to be accountable for the work.","order":9,"name":"Ethics","group":{"name":"EthicsHeading","label":"Author contributions"}}]}}